Jonathan Karush 3/1/23 Jonathan Karush 3/1/23 Wall Street Journal: Congress Investigates How Pharma Middlemen Affect Drug Prices Wall Street Journal Read More Jonathan Karush 2/17/23 Jonathan Karush 2/17/23 'In the crosshairs': PBM reform effort intensifies on Capitol Hill Politico Read More Jonathan Karush 2/9/23 Jonathan Karush 2/9/23 UnitedHealth, CVS/Aetna, Cigna pulled in close to a trillion dollars last year, mostly as drug middlemen Wendell Potter HEALTHCARE un-covered Read More Jonathan Karush 10/20/22 Jonathan Karush 10/20/22 Pharmacy caucus may elevate drug issues in 2023 WWLP Read More Jonathan Karush 6/3/22 Jonathan Karush 6/3/22 Federal Trade Commission And Congress Want To Rein In PBMs Forbes Magazine Read More Jonathan Karush 5/28/19 Jonathan Karush 5/28/19 How Drug Prices Work Wall Street Journal Read More Newer Posts
Jonathan Karush 3/1/23 Jonathan Karush 3/1/23 Wall Street Journal: Congress Investigates How Pharma Middlemen Affect Drug Prices Wall Street Journal Read More
Jonathan Karush 2/17/23 Jonathan Karush 2/17/23 'In the crosshairs': PBM reform effort intensifies on Capitol Hill Politico Read More
Jonathan Karush 2/9/23 Jonathan Karush 2/9/23 UnitedHealth, CVS/Aetna, Cigna pulled in close to a trillion dollars last year, mostly as drug middlemen Wendell Potter HEALTHCARE un-covered Read More
Jonathan Karush 10/20/22 Jonathan Karush 10/20/22 Pharmacy caucus may elevate drug issues in 2023 WWLP Read More
Jonathan Karush 6/3/22 Jonathan Karush 6/3/22 Federal Trade Commission And Congress Want To Rein In PBMs Forbes Magazine Read More